Search

Search results

504 results found

SPONTANEOUS CLOSURE OF A MACULAR HOLE AFTER FOUR FAILED VITRECTOMIES IN THE SETTING OF NF-1.

Publication: Journal Article

Wannamaker, Kendall, Robert Sharpe, and Jan Kylstra. 2016. “SPONTANEOUS CLOSURE OF A MACULAR HOLE AFTER FOUR FAILED VITRECTOMIES IN THE SETTING OF NF-1.”. Retin Cases Brief Rep.

Meet the Experts and Related Reading

Page

Meet the Experts Janey Wiggs, MD, PhD Associate Director of the Ocular Genomics Institute at Mass. Eye and Ear Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School Dr. Wiggs is a board-certified medical geneticist specializing in the genetics of glaucoma with particular interest...

Three New Glaucoma-related Genes Identified

News: January 12, 2016

Janey Wiggs, MD, PhD, is the lead author on the article, “ Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma” published online in Nature Genetics on January 11, 2016. Dr. Wiggs and colleagues at Case Western Reserve University...

Luk H. Vandenberghe, PhD, receives RPB Nelson Trust Award for Retinitis Pigmentosa

News: December 21, 2016

Boston, Mass. — Luk H. Vandenberghe, PhD, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear and an Assistant Professor of Ophthalmology at Harvard Medical School, has been awarded a Nelson Trust Award for Retinitis Pigmentosa by Research to Prevent Blindness (RPB) in the...

ARVO 2016

News: April 28, 2016

From May 1 st to May 5 th, more than 11,000 people attended the Association for Research in Vision and Ophthalmology (ARVO) 2016 Annual Meeting in Seattle, WA. Eye and vision researchers from more than 75 countries presented their current research, discussed emerging technologies, and strategized...

Reza Dana Elected to Academia Ophthalmologica Internationalis

News: March 02, 2016

In February 2016, Reza Dana, MD, MPH, MSc, Vice Chair for Academic Programs for the Harvard Medical School (HMS) Department of Ophthalmology, and Director of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear, was elected to Academia Ophthalmologica Internationalis (AOI), one of...

New Research Links Mitochondrial Dysfunction to Development of Fuchs’ Endothelial Corneal Dystrophy (FECD), a Common Cause of Corneal Swelling and Blindness

News: March 07, 2016

Findings could eventually lead to first non-surgical therapies and treatments for FECD. BOSTON -- Researchers at Schepens Eye Research Institute of Massachusetts Eye and Ear have shown a link between mitochondrial dysfunction in corneal endothelial cells and the development of Fuchs’ Endothelial...

Researchers Find Immunosuppressive Medication An Effective Treatment For Ocular Graft-Versus-Host-Disease

News: April 13, 2016

A complication associated with bone marrow transplantation, graft-versus-host-disease occurs when a transplanted immune system attacks certain parts of a host’s body, and may cause severe dry eye and damage to the cornea. A clinical trial at Massachusetts Eye and Ear showed that topical doses of...

Selecta Biosciences obtains exclusive license to proprietary gene therapy vector from Massachusetts Eye and Ear

News: May 19, 2016

Selecta is licensing Anc80 from Massachusetts Eye and Ear for a rare genetic disease with options on additional pre-specified indications. By combining Anc80 with Selecta’s investigational drug candidate, SVP-Rapamycin (SEL-110), Selecta is seeking to advance a new gene therapy platform designed to...

Lotfi B. Merabet, PhD, OD, Receives Low Vision Research Award

News: June 23, 2016

Boston, Mass. — Lotfi B. Merabet, PhD, OD, MPH , an optometrist and vision researcher at Massachusetts Eye and Ear and an Associate Professor of Ophthalmology at Harvard Medical School, is the 2016 recipient of the Low Vision Research Award from Research to Prevent Blindness (RPB) and the Lions...